By Drug Class / Mechanism

Combination Counterirritant (Menthol + Camphor / Methyl Salicylate) Market Analysis

Cross-industry research covering Combination Counterirritant (Menthol + Camphor / Methyl Salicylate) across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Combination Counterirritant (Menthol + Camphor / Methyl Salicylate)

Medical Cold Gel Market to Reach USD 1.8 Billion by 2033 at 5.2% CAGR

Pharmaceuticals·Market: USD 1.21 Billion (2025)·CAGR: 5.2%

Dual or triple active ingredient formulations provide layered sensory relief and are common in professional-grade and sports-medicine formats. Methyl salicylate provides a mild topical NSAID-like effect; camphor adds a warming counterpoint. Regulatory classification under FDA OTC drug monograph CFR 21 Part 348 governs maximum concentrations.

22%

Market Share

5.2%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments